Danaher
Beckman Coulter Life Sciences, Pillar Biosciences to Develop NGS Cancer Tests
Pillar will develop a series of tests for use on Beckman Coulter's Biomek NGeniuS Next Generation Library Preparation System.
People in the News at CareDx, Myriad Genetics, Danaher, 23andMe, Syantra, More
Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of Oct. 30, 2023.
The company saw softer than anticipated demand in its life sciences business while revenue from its diagnostics segment was down 16 percent.
Business in China is not going as well as expected for many US companies, especially those selling sequencing- and mass spec-related research tools.
Danaher Agrees to Provide Cepheid Tuberculosis Test to Global Fund at Cost
The tuberculosis test cartridges will be offered at $7.97 each to the Global Fund and less-developed countries eligible for Cepheid's Global Access Program.
Aug 28, 2023
Danaher to Acquire Abcam for $5.7B
Apr 25, 2023
Apr 19, 2023
Nov 7, 2022
Cepheid Nabs CE Mark for Group B Strep Test
Jul 25, 2022